211 related articles for article (PubMed ID: 38137391)
1. New Enhancing MRI Lesions Associate with IL-17, Neutrophil Degranulation and Integrin Microparticles: Multi-Omics Combined with Frequent MRI in Multiple Sclerosis.
Illes Z; Jørgensen MM; Bæk R; Bente LM; Lauridsen JT; Hyrlov KH; Aboo C; Baumbach J; Kacprowski T; Cotton F; Guttmann CRG; Stensballe A
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137391
[TBL] [Abstract][Full Text] [Related]
2. Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.
Bar-Or A; Montalban X; Hu X; Kropshofer H; Kukkaro P; Coello N; Ludwig I; Willi R; Zalesak M; Ramanathan K; Kieseier BC; Häring DA; Bagger M; Fox E
Neurol Ther; 2023 Feb; 12(1):303-317. PubMed ID: 36534274
[TBL] [Abstract][Full Text] [Related]
3. CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.
Mazzucco M; Mannheim W; Shetty SV; Linden JR
Fluids Barriers CNS; 2022 Feb; 19(1):13. PubMed ID: 35135557
[TBL] [Abstract][Full Text] [Related]
4. Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
Blaabjerg M; Hemdrup AL; Drici L; Ruprecht K; Garred P; Höftberger R; Kristensen BW; Kondziella D; Sejbaek T; Hansen SW; Nielsen HH; Jensen P; Meyer M; Paul F; Lassmann H; Larsen MR; Illes Z
Front Immunol; 2018; 9():741. PubMed ID: 29740431
[TBL] [Abstract][Full Text] [Related]
5. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
[TBL] [Abstract][Full Text] [Related]
6. A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.
Gold J; Marta M; Meier UC; Christensen T; Miller D; Altmann D; Holden D; Bianchi L; Adiutori R; MacManus D; Yousry T; Schmierer K; Turner B; Giovannoni G
Mult Scler Relat Disord; 2018 Aug; 24():123-128. PubMed ID: 29990894
[TBL] [Abstract][Full Text] [Related]
7. Immune system-related plasma extracellular vesicles in healthy aging.
Zhang X; Ma S; Huebner JL; Naz SI; Alnemer N; Soderblom EJ; Aliferis C; Kraus VB
Front Immunol; 2024; 15():1355380. PubMed ID: 38633262
[TBL] [Abstract][Full Text] [Related]
8. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F
Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profile of extracellular vesicles in maternal plasma of women with fetal death.
Gallo DM; Fitzgerald W; Romero R; Gomez-Lopez N; Gudicha DW; Than NG; Bosco M; Chaiworapongsa T; Jung E; Meyyazhagan A; Suksai M; Gotsch F; Erez O; Tarca AL; Margolis L
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2177529. PubMed ID: 36813269
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis.
Waubant E
Dis Markers; 2006; 22(4):235-44. PubMed ID: 17124345
[TBL] [Abstract][Full Text] [Related]
11. MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
Maranzano J; Rudko DA; Nakamura K; Cook S; Cadavid D; Wolansky L; Arnold DL; Narayanan S
Neurology; 2017 Aug; 89(7):714-721. PubMed ID: 28724581
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
Choi S; Spini M; Hua J; Harrison DM
PLoS One; 2021; 16(4):e0249973. PubMed ID: 33901207
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
16. Patterns of blood-brain barrier breakdown in inflammatory demyelination.
Hawkins CP; Mackenzie F; Tofts P; du Boulay EP; McDonald WI
Brain; 1991 Apr; 114 ( Pt 2)():801-10. PubMed ID: 2043950
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory interleukin 1 receptor antagonist concentration in plasma correlates with blood-brain barrier integrity in the primary lesion area in traumatic brain injury patients.
To XV; Donnelly P; Maclachlan L; Mahady K; Apellaniz EM; Cumming P; Winter C; Nasrallah F
Brain Behav Immun Health; 2023 Aug; 31():100653. PubMed ID: 37415924
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Proton Exchange Rate (k
Ye H; Shaghaghi M; Chen Q; Zhang Y; Lutz SE; Chen W; Cai K
J Magn Reson Imaging; 2021 Feb; 53(2):408-415. PubMed ID: 32975008
[TBL] [Abstract][Full Text] [Related]
19. Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis.
Dalton CM; Miszkiel KA; Barker GJ; MacManus DG; Pepple TI; Panzara M; Yang M; Hulme A; O'Connor P; Miller DH
J Neurol; 2004 Apr; 251(4):407-13. PubMed ID: 15083284
[TBL] [Abstract][Full Text] [Related]
20. Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis.
Giovannoni G; Silver NC; Good CD; Miller DH; Thompson EJ
Eur Neurol; 2000; 44(4):222-8. PubMed ID: 11096222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
